Rick Doblin

The Multidisciplinary Association for Psychedelic Studies (MAPS) introduced "Music is the Bridge," a new campaign that combines artist-curated playlists with free psychedelic education. Starting Monday, the project aims to make psychedelic experiences safer, more accessible and more meaningful....

The Food and Drug Administration (FDA) this week declined to approve the use of MDMA — popularly known as Ecstasy or Molly — for MDMA-assisted therapy for treating PTSD, disappointing many Americans who suffer with intractable mental health conditions and had pinned their hopes on the treatment....

In an engaging episode of Benzinga’s Cannabis Insider podcast, hosts Patricio Liddle and Nicolás Rodríguez welcomed Cody Shandraw, president of Healing Realty Trust, to discuss the role of real estate in the burgeoning sector of psychedelic therapies. Shandraw, who spearheads the strategic...

A decade after it was founded as a wholly-owned subsidiary of the Multidisciplinary Association for Psychedelic Studies (MAPS), MAPS Public Benefit Corporation has secured over $100 million in a Series A private stock sale. The funds will support the final stages of its application for...

Presenting the Honey Badger Award to Rick Doblin at Psychedelic Science 2023 was Zappy Zapolin's highlight moment. "Rick exemplifies all the attributes of the ferocious honey badger, combined with a compassionate heart, which is why I felt he deserved this recognition." The award was...

The Alexander Shulgin Research Institute (ASRI), the organization advancing the renowned chemist’s scientific work and legacy, presented novel psychoactive compounds at the MAPS' Psychedelic Science 2023 last month in Denver.   ASRI co-founder and president Dr....

The Multidisciplinary Association for Psychedelic Studies (MAPS) sponsored a Psychedelic Science conference in Denver last week, which gathered over 12,000 people from the entire psychedelics spectrum.  The list of attendees included the most knowledgeable individuals ...

In a moment of riveting candor at MAPS' Psychedelic Science 2023 conference in Denver, Colorado, Benzinga Cannabis' Lara Goldstein captured the potent essence of Psycheceutical Bioscience Inc (OTC: BWVI)'s Zappy Zapolin's passionate words in an exclusive interview. "The future...

(Part four of a four-part series) In addition to psilocybin’s therapeutic value, ongoing discussion involves other issues such as how its potential commercialization process is unfolding. In terms of ethics, Numinus (OTCMKTS: NUMIF) co-founder and CEO Payton...

The freshest news traversing many of the major institutions, researchers' and activists’ accounts on Twitter is the recent release of a docu-series based on writer Michael Pollan’s 2018 book “How To Change Your Mind: What the science of psychedelics teaches us...

Christie’s, the legendary art and luxury auction house, along with Dialectic and Vine Ventures, will auction off NFT works for those interested in digital art and supporting scientific studies. In this case, the research is related to the legalization of psychedelic...

This article was originally published on Psychedelic Spotlight and appears here with permission. The MAPS founder, who will speak at psychedelic conference Wonderland Miami next month, predicts clinics that administer the medicines will become licensing bodies for personal use. Psychedelics...

Wesana Health (CSE: WESA) (OTCQB: WSNAF) and the Multidisciplinary Association for Psychedelic Studies (MAPS) are teaming up to analyze the effectiveness of MDMA-assisted therapy in the treatment of traumatic brain injury (TBI). Wesana Health went public in May with a focus on developing...

Two of the most prominent companies in the psychedelics space released their financials for the first quarter of 2021. Compass Pathways (NASDAQ: CMPS) and MindMed (NASDAQ: MNMD) remain the only two companies in psychedelics to reach a major U.S. stock exchange. Both companies presented net losses...

These days, the psychedelics finds itself in the midst of a public debate around the moral implications of patents and intellectual property for certain medicines and treatments. The conversation began last month when Compass Pathways (NASDAQ: CMPS) introduced a series of patent...